Patents by Inventor Fu-Dong Shi

Fu-Dong Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF FPR1 AND METHODS OF USING THE SAME
    Publication number: 20240109897
    Abstract: The disclosure provides at compounds of Formula I, compositions comprising the same, and methods of using the same, including use in treating diseases, disorders of conditions mediated by the signaling of formyl peptide receptor 1 (FPR1).
    Type: Application
    Filed: January 21, 2021
    Publication date: April 4, 2024
    Inventors: Fu-Dong SHI, Yongjun WANG, Qiang LIU, Zhiguo LI, Tianwei MA, Zheng HUANG, Feng SHI
  • Nicotinic attenuation of CNS inflammation and autoimmunity
    Patent number: 10080747
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: September 25, 2018
    Assignee: Dignity Health
    Inventors: Fu-Dong Shi, Ronald J. Lukas, Timothy Vollmer
  • NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY
    Publication number: 20170119752
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Application
    Filed: January 5, 2017
    Publication date: May 4, 2017
    Applicant: DIGNITY HEALTH
    Inventors: Fu-Dong Shi, Ronald J. Lukas, Timothy Vollmer
  • Nicotinic attenuation of CNS inflammation and autoimmunity
    Patent number: 9566273
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: February 14, 2017
    Assignee: Dignity Health
    Inventors: Fu-Dong Shi, Ronald J. Lukas, Timothy Vollmer
  • NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY
    Publication number: 20140364463
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Application
    Filed: August 4, 2014
    Publication date: December 11, 2014
    Applicant: DIGNITY HEALTH
    Inventors: Fu-Dong Shi, Ronald J. Lukas, Timothy Vollmer
  • Nicotinic attenuation of CNS inflammation and autoimmunity
    Patent number: 8841329
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: September 23, 2014
    Assignee: Dignity Health
    Inventors: Fu-Dong Shi, Ronald J. Lukas, Timothy Vollmer
  • NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY
    Publication number: 20120322832
    Abstract: The present invention relates to methods of treating and/or ameliorating the severity of inflammation and autoimmunity in the central nervous system (CNS). In one embodiment, the present invention provides a method of treating multiple sclerosis by administering a therapeutically effective dosage of nicotine, or a pharmaceutical equivalent, analog, derivative, or salt thereof.
    Type: Application
    Filed: September 11, 2009
    Publication date: December 20, 2012
    Applicant: CATHOLIC HEALTHCARE WEST
    Inventor: Fu-Dong Shi